About
Basic Data Updated:
1 month agoThe Corporate was formerly known as Reseapro Pharma Private Limited. The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Lakh and a paid-up capital of Rs 1.00 Lakh, as per the Ministry of Corporate Affairs (MCA) records.
Mukesh Das and Tanmaya Mohapatra serve as directors at the Company.
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24290OR2020PTC032719 |
| Company No. | 032719 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 17 Feb 2020 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Cuttack |
Financials of S2M Lifescience Private Limited
S2M Lifescience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.14% increase. The company also saw a substantial improvement in profitability, with a 209.64% increase in profit. The company's net worth Soared by an impressive increase of 28.44%.
Corporate Structure
Unlock access to S2M Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in S2M Lifescience Private Limited
Unlock and access historical data on people associated with S2M Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S2M Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S2M Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
3 years 3 months Recent activity within the organization
Annual General Meeting
S2M Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
S2M Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
31 Mar 2023Director Appointment
Mukesh Kumar Das was appointed as a Director was appointed as a Director on 10 Jun 2021 & has been associated with this company since 3 years 3 months .
10 Jun 2021Director Appointment
Tanmaya Mohapatra was appointed as a Director was appointed as a Director on 17 Feb 2020 & has been associated with this company since 4 years 7 months .
17 Feb 2020Company Incorporation
S2M Lifescience Private Limited was registered on 17 Feb 2020 with Roc Cuttack & aged 4 years 7 months as per MCA records.
17 Feb 2020
Frequently asked questions
What is the Incorporation or founding date of S2M Lifescience Private Limited?
